![](https://investorshub.advfn.com/uicon/78991.png?cb=1630499252)
Monday, March 26, 2018 8:14:12 AM
Possible breakthrough designation coming as well.
Best of luck to all $IPIX longs.
A lot of good things are about to happen with our little IPIX. And the pace of when they start happening can progress very quickly.
Maybe you're familiar with this....
Journal of Pharmacogenomics &
Pharmacoproteomics Ali et al., J Pharmacogenomics Pharmacoproteomics
2017, 8:2
DOI: 10.4172/ 2153-0645.1000171
Newer carbapenems: Doripenem, Imipenem/MK-7655, Brilacidin,
MX-2401 (lipopeptide antibiotic), OP0595 (a new diazabicyclooctane),
Quinolones, Macrocyclic antibiotics, Pleuromutilin, Glycocycline,
Ketolides, Lipopeptides, Iciaprim, Oxazolidinone.
Brilacidin (PMX-30063)
Actively ruptures the bacterial cell membrane structures in gramnegative
enteric bacteria [17].
17. Boucher HW, Talbot GH, Benjamin DK, Bradley J, Guidos RJ, et al.
(2013) 10×'20 progress-development of new drugs active against gramnegative
bacilli: an update from the Infectious Diseases Society of
America. Clin Infect Dis 56: 1685-1694.
https://www.omicsonline.org/open-access/modes-of-action-of-some-recently-and-previously-discovered-and-usedantimicrobial-agentsdrugs-and-molecules-an-overview-2153-0645-1000171.pdf
Message in reply to:
Do you see any article, any mention of B as a new class of ABX?
Absolutely not
Does the scientific community talking about it as new MOA ABX - no
That is my point
"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM